Painazol Shingles Symptom Relief Cream

Manufacturer
Hello Life, Inc. | Cosmetic Specialty labs, Inc. | HelloLife, Inc. | Apotheca Inc.
Effective date
2018-12-26
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:39:24

Label at a glance#

ProductPainazol Shingles Symptom Relief Cream
Active ingredientSIMABA CEDRON SEED, DAPHNE MEZEREUM BARK, PHYTOLACCA AMERICANA ROOT, SEMPERVIVUM TECTORUM LEAF, CROTON TIGLIUM SEED, MENTHA PIPERITA, TOXICODENDRON PUBESCENS LEAF, SOLANUM DULCAMARA TOP, RANUNCULUS BULBOSUS, GRINDELIA HIRSUTULA FLOWERING TOP, SALICYLIC ACID
Label structure10 sections

Indications and uses

to temporarily relieve symptoms commonly associated with shingles, such as: shingles pain intense itching eruptions rash burning skin

Dosage and administration

Apply cream directly to the affected area, 2-6 times daily, or, as needed.

Storage and handling

store in a cool, dry place product must not come in contact with metal do not store next to electrical devices or appliances

Label contents#

Full prescribing information#

Active Ingredients (per dose)

OTC - ACTIVE INGREDIENT SECTION

Cedron 3C, Mezereum 1X, Phytolacca 1X, Sempervivum 2X HPUS

Croton 3X, Mentha pip 1X, Rhus tox 3X HPUS

Dulcamara 2X, Ranunc bulb 3X HPUS

Grindelia 1X HPUS

Salicylicum ac 3X HPUS

The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States. Product indications based on Homeopathic Materia Medica.

Purpose

OTC - PURPOSE SECTION

Cedron 3C, Mezereum 1X, Phytolacca 1X, Sempervivum 2X HPUS.................Shingles pain

Croton 3X, Mentha pip 1X, Rhus tox 3X HPUS................................................Intense itching

Dulcamara 2X, Ranunc bulb 3X HPUS............................................................Eruptions

Grindelia 1X HPUS........................................................................................Rash

Salicylicum ac 3X HPUS...............................................................................Burning skin

Uses

INDICATIONS & USAGE SECTION

to temporarily relieve symptoms commonly associated with shingles, such as:

  • shingles pain
  • intense itching
  • eruptions
  • rash
  • burning skin

Warnings

WARNINGS SECTION

Ask a doctor before use if

  • you are taking any other medications
  • you have a medical condition

Stop use and ask a doctor if

OTC - STOP USE SECTION

symptoms persist or worsen.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children.

OTHER SAFETY INFORMATION

For external use only. Use only as directed.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply cream directly to the affected area, 2-6 times daily, or, as needed.

Other information

STORAGE AND HANDLING SECTION

  • store in a cool, dry place
  • product must not come in contact with metal
  • do not store next to electrical devices or appliances

Inactive ingredients

INACTIVE INGREDIENT SECTION

aloe barbadensis leaf, purified water, methylsulfonylmethane, emu oil, cetearyl alcohol, caprylyl glycol, phenoxyethanol, sorbitol, carbomer, sodium hydroxide, lavandula angustifolia (lavender) oil, coriandrum sativum (coriander) fruit oil.

Questions or comments?

OTC - QUESTIONS SECTION

You can email us at info@hellolife.net or call us toll-free at 1.800.875.0850 Monday through Friday, 9am-5pm ET. www.hellolife.net

DESCRIPTION SECTION

Mftd for: HelloLife, LLC. 4460 44th St SE, Ste. C-600, Grand Rapids, MI 49512

FDA Pharmaceutical Establishment #3009727070

DO NOT USE IF TAMPER SEAL IS BROKEN

www.hellolife.net

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC #49726-033-04

PAINAZOL TM

Shingles Symptom Relief Cream

FOR EXTERNAL USE ONLY

Homeopathic (OTC) Medicine

4.5 oz (128 g)

Painazol Shingles labelPainazol Shingles label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49726-033-042021-07-23C16284748780-1c7ccaba7-160e-fd44-e053-dadaa90aa01bDrug Facts

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CROTON TIGLIUM SEEDACTIVE INGREDIENT0HK2GZK66E1
DAPHNE MEZEREUM BARKACTIVE INGREDIENTX2N6E405GV1
GRINDELIA HIRSUTULA FLOWERING TOPACTIVE INGREDIENTIDB0NAZ6AI1
MENTHA PIPERITAACTIVE INGREDIENT79M2M2UDA91
PHYTOLACCA AMERICANA ROOTACTIVE INGREDIENT11E6VI8VEG1
RANUNCULUS BULBOSUSACTIVE INGREDIENTAEQ8NXJ0MB1
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZ1
SEMPERVIVUM TECTORUM LEAFACTIVE INGREDIENT3DGJ7BUA011
SIMABA CEDRON SEEDACTIVE INGREDIENTKHI40967MV1
SOLANUM DULCAMARA TOPACTIVE INGREDIENTKPS1B1162N1
TOXICODENDRON PUBESCENS LEAFACTIVE INGREDIENT6IO182RP7A1
CROTON TIGLIUM SEEDACTIVE MOIETY0HK2GZK66E1
DAPHNE MEZEREUM BARKACTIVE MOIETYX2N6E405GV1
GRINDELIA HIRSUTULA FLOWERING TOPACTIVE MOIETYIDB0NAZ6AI1
MENTHA PIPERITAACTIVE MOIETY79M2M2UDA91
PHYTOLACCA AMERICANA ROOTACTIVE MOIETY11E6VI8VEG1
RANUNCULUS BULBOSUSACTIVE MOIETYAEQ8NXJ0MB1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ1
SEMPERVIVUM TECTORUM LEAFACTIVE MOIETY3DGJ7BUA011
SIMABA CEDRON SEEDACTIVE MOIETYKHI40967MV1
SOLANUM DULCAMARA TOPACTIVE MOIETYKPS1B1162N1
TOXICODENDRON PUBESCENS LEAFACTIVE MOIETY6IO182RP7A1
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0X1
CAPRYLYL GLYCOLINACTIVE INGREDIENT00YIU5438U1
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1S1
CORIANDER OILINACTIVE INGREDIENT7626GC95E51
DIMETHYL SULFONEINACTIVE INGREDIENT9H4PO4Z4FT1
EMU OILINACTIVE INGREDIENT344821WD611
LAVENDER OILINACTIVE INGREDIENTZBP1YXW0H81
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I1
SORBITOLINACTIVE INGREDIENT506T60A25R1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49726-03349726-033-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 238 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGRANULE, FOR SUSPENSION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1SCAPSULE, EXTENDED RELEASE / ORAL9.43 mgExact identifier — unii candidate
9 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET, COATED / ORALNAExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INFILTRATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISPRAY / NASALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRADERMALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / SUBARACHNOIDADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / ORAL9120 mgExact identifier — unii candidate
174 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION / INTRA-ARTICULAR45 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25ROINTMENT / TOPICAL10 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISYRUP / ORAL71 mg/5mlExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IDROPS / OPHTHALMICNAExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS136.55 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPASTE / DENTAL14.6 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPASTE, DENTIFRICE / DENTAL14 %w/wExact identifier — unii candidate
44 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / EXTRACORPOREALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TAEROSOL, FOAM / TOPICAL72 mgExact identifier — unii candidate
6 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1SAEROSOL, FOAM / TOPICAL21 mgExact identifier — unii candidate
9 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, CHEWABLE / ORAL3555 mgExact identifier — unii candidate
44 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRAVENOUS456 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ILOTION, AUGMENTED / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM, SOLUBLE / ORAL11 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IDISC / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / DENTALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICAPSULE / ORAL60 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / EPIDURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ILIQUID / ORAL2 mg/5mlExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRASYNOVIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IEMULSION / OPHTHALMIC0.02 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IENEMA / RECTAL0.44 %v/vExact identifier — unii candidate
174 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1SSPRAY / TOPICAL1 %w/wExact identifier — unii candidate
9 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS1.04 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, EXTENDED RELEASE / ORAL428 mgExact identifier — unii candidate
44 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TGEL / TOPICAL14 mgExact identifier — unii candidate
6 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / DENTALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1STABLET, EXTENDED RELEASE / ORAL800 mgExact identifier — unii candidate
9 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSOLUTION / NASAL25 mg/1mlExact identifier — unii candidate
44 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISWAB / TOPICAL0.01 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET, DELAYED RELEASE / ORAL4 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RINJECTION / INTRALESIONAL45 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAVENOUS78 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISHAMPOO / TOPICAL3 mgExact identifier — unii candidate
174 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RLIQUID / ORAL53460 mgExact identifier — unii candidate
44 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, DELAYED RELEASE / ORAL0.01 mgExact identifier — unii candidate
44 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRADERMALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPOWDER / ORAL36000 mgExact identifier — unii candidate
44 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INFILTRATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION/ DROPS / OPHTHALMICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IEMULSION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRATUMORADJ PHExact identifier — unii candidate
174 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c7ceb330-3c3d-0fee-e053-2a95a90affea9ef8bdfd-7115-4581-b940-782c40c0c2d12021-07-23WarningsExact identifier
spl set id: 9ef8bdfd-7115-4581-b940-782c40c0c2d1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.